09966.HK
Alphamab Oncology
HKSE · Healthcare · Biotechnology · CN
HKD 6.49
−0.92%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- -0.07x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -2.05x
- Net debt / EBITDA
- 0.87x
Liquidity & coverage
- Current ratio
- 4.02x
- Quick ratio
- 3.68x
- Cash ratio
- 3.40x
- Interest coverage
- -30.62x
- EBITDA / interest
- -20.47x
- Working capital
- HKD 1.5B
Cash & dividend
- FCF / debt
- -0.64x
- Cash flow / debt
- -0.58x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026